# NRG-GU005 (NCT03367702)

> Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03367702
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: NRG Oncology
- Conditions: Stage II Prostate Adenocarcinoma AJCC v7
- Interventions: Intensity-Modulated Radiation Therapy; Quality-of-Life Assessment; Questionnaire Administration; Stereotactic Body Radiation Therapy
- Enrollment: 692
- Primary outcome: Incidence of patients-reported gastrointestinal and genitourinary toxicity
- Primary outcome: Disease free survival

## Indexed commentary on NRG-GU005 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 39
- YouTube: 3
- Podcasts: 3
- Bluesky threads: 2

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nrg-gu005-nct03367702

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03367702", "email": "<work email>"}; the inbox owner confirms by the emailed link.